ITSSD: Russia Can Secure Greatest Biotech Market Advances Following US, Not EU Innova... ( PRINCETON N.J. March 21 -- In a ...)

ITSSD: Russia Can Secure Greatest Biotech Market Advances Following US, Not EU Innovation Model

Date:3/21/2008

PRINCETON, N.J., March 21 /PRNewswire-USNewswire/ -- In a short article published today by the Washington Legal Foundation, US international trade and business lawyer Lawrence Kogan and Russian Government lawyer Yelena Bakulina highlight the common bases in Russian and US history that have triggered new thinking in Russia about how to use privately owned patent rights and cooperative government-university-industry technology transfer arrangements to secure successful market commercialization and peaceful adaptation of publicly-owned bio-warfare technologies.

The article arose from Kogan's June 28, 2007 presentation at a symposium convened by the Vyatka State University, Kirov, Russia, as part of a longstanding joint Russian-US cooperative nonproliferation program overseen by the International Science and Technology Center (ISTC), Moscow, Russia.

According to Bakulina and Kogan, "The [US] federal government['s]...transference of innovation from energy, space, and defense to that of the private sector, and...the American experience in innovation and intellectual property may be advantageous to use in Russia..."

Furthermore as the authors note, "The Kirov Region certainly has the potential to develop effective innovation systems supported by the investment and protection of privately owned intellectual property in the sphere of modern high tech technology. If properly managed...this could create jobs, know-how and other economic and social benefits in the Kirov Region."

"Such an approach," adds Kogan, "would allow Russian biotechnology markets to leapfrog those of the European Union to capture a greater share of the global marketplace for biomedical and bioenvironmental products and processes. Unfortunately, the current EU innovation model is fixated on governmental market control via regulation rather than on market facilitation via economic incentives that ease the burdens and costs of doing business," emphasizes Kogan. "The
'/>"/>

0

GOOD

Page: 1 2
Related biology technology :

1. Nova Biosource Fuels Announces First Funding Under $41 Million Senior Secured Credit Facility
2. Amarin Secures Global Intellectual Property Rights for Lipid Programs
3. Ranier Technology Secures GBP8m Funding for its Cadisc Replacement Spinal Discs
4. Halogen Announces Record Year - Company Solidifies Leadership Position, Secures Strategic Wins Over Competition
5. ProMetic provides business update - Over $35 million worth of business secured in January
6. Energy Conversion Devices and United Solar Ovonic Enter Into New $55 Million Secured Credit Facility Agreements
7. Taligen Therapeutics Secures Series B Financing
8. Neptune Technologies & Bioressources Inc. Secures Access to Nationwide Consumer Mass Market in the United States
9. Dendreon Secures $130 Million Committed Equity Financing Facility
10. Secure Symbology: Making New Jersey Proud While Saving Lives
11. Apollo Endosurgery, Inc. Secures $11.5 Million in Series A Financing.

Post Your Comments:

ITSSD: Russia Can Secure Greatest Biotech Market Advances Following US, Not EU Innova...( PRINCETON N.J. March 21 -- In a ...)